Aluminosis (of lung)
ICD-10 J63.0 is a billable code used to indicate a diagnosis of aluminosis (of lung).
Aluminosis, classified under ICD-10 code J63.0, is a type of pneumoconiosis caused by the inhalation of aluminum dust. This condition primarily affects the lung's parenchyma, leading to inflammation and fibrosis. Clinically, patients may present with symptoms such as chronic cough, dyspnea, and chest discomfort, which can progressively worsen over time. The disease is characterized by the accumulation of aluminum particles in the lung tissue, leading to scarring and impaired respiratory function. Diagnostic considerations include a thorough occupational history, chest radiography, and pulmonary function tests to assess the extent of lung impairment. High-resolution computed tomography (HRCT) may also be utilized to visualize lung changes. Disease progression can vary, with some patients experiencing significant respiratory decline, while others may remain stable for years. Early diagnosis and intervention are crucial to managing symptoms and preventing further lung damage.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
J63.0 specifically covers aluminosis, which is a lung condition resulting from the inhalation of aluminum dust. It is classified under pneumoconiosis and is distinct from other forms of pneumoconiosis such as silicosis or asbestosis.
J63.0 should be used when there is a confirmed diagnosis of aluminosis due to aluminum exposure, particularly in patients with a relevant occupational history. It is important to differentiate it from other pneumoconiosis codes based on the specific type of dust inhaled.
Documentation for J63.0 should include a detailed occupational history indicating exposure to aluminum dust, clinical symptoms, results from imaging studies, and pulmonary function tests that demonstrate lung impairment.
